These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 38114732)
21. Eye movements as predictor of cognitive improvement after cognitive remediation therapy in patients with schizophrenia. Zhu J; Li J; Zhou L; Xu L; Pu C; Huang B; Zhou Q; Lin Y; Tang Y; Yang L; Shi C Front Psychiatry; 2024; 15():1395198. PubMed ID: 38690204 [TBL] [Abstract][Full Text] [Related]
22. Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment. Iasevoli F; Balletta R; Gilardi V; Giordano S; de Bartolomeis A Neuropsychiatr Dis Treat; 2013; 9():1113-20. PubMed ID: 23950651 [TBL] [Abstract][Full Text] [Related]
23. The Effects of Electroconvulsive Therapy Augmentation of Antipsychotic Treatment on Cognitive Functions in Patients With Treatment-Resistant Schizophrenia. Vuksan Ćusa B; Klepac N; Jakšić N; Bradaš Z; Božičević M; Palac N; Šagud M J ECT; 2018 Mar; 34(1):31-34. PubMed ID: 29053485 [TBL] [Abstract][Full Text] [Related]
24. Identifying cognitive remediation change through computational modelling--effects on reinforcement learning in schizophrenia. Cella M; Bishara AJ; Medin E; Swan S; Reeder C; Wykes T Schizophr Bull; 2014 Nov; 40(6):1422-32. PubMed ID: 24214932 [TBL] [Abstract][Full Text] [Related]
25. Randomized controlled trial on adjunctive cognitive remediation therapy for chronically hospitalized patients with schizophrenia. Lu H; Li Y; Li F; Jiao X; Shi W; Guo K; Liu P Shanghai Arch Psychiatry; 2012 Jun; 24(3):149-54. PubMed ID: 25324619 [TBL] [Abstract][Full Text] [Related]
26. Combined social cognitive and neurocognitive rehabilitation strategies in schizophrenia: neuropsychological and psychopathological influences on Theory of Mind improvement. Bechi M; Bosia M; Spangaro M; Buonocore M; Cocchi F; Pigoni A; Piantanida M; Guglielmino C; Bianchi L; Smeraldi E; Cavallaro R Psychol Med; 2015 Nov; 45(15):3147-57. PubMed ID: 26062741 [TBL] [Abstract][Full Text] [Related]
27. The Implementation and Review of Cognitive Remediation Training for First Episode Psychosis in Singapore. Chong NIM; Maniam Y; Chua YC; Tang C Front Psychiatry; 2021; 12():784935. PubMed ID: 34916979 [No Abstract] [Full Text] [Related]
28. The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia. Sumiyoshi T; Jayathilake K; Meltzer HY Schizophr Res; 2003 Jan; 59(1):7-16. PubMed ID: 12413636 [TBL] [Abstract][Full Text] [Related]
29. Donepezil and cognitive remediation therapy to augment treatment of alcohol use disorder related mild cognitive impairment (AUD-MCI): An open label pilot study with historical controls. Bell MD; Pittman B; Petrakis I; Yoon G Subst Abus; 2021; 42(4):412-416. PubMed ID: 33284058 [No Abstract] [Full Text] [Related]
30. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Meltzer HY; McGurk SR Schizophr Bull; 1999; 25(2):233-55. PubMed ID: 10416729 [TBL] [Abstract][Full Text] [Related]
31. The effect of high vs. low dose lurasidone on eye movement biomarkers of prefrontal abilities in treatment-resistant schizophrenia. Karpouzian-Rogers T; Stocks J; Meltzer HY; Reilly JL Schizophr Res; 2020 Jan; 215():314-321. PubMed ID: 31706786 [TBL] [Abstract][Full Text] [Related]
32. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Cuesta MJ; Peralta V; Zarzuela A Schizophr Res; 2001 Mar; 48(1):17-28. PubMed ID: 11278151 [TBL] [Abstract][Full Text] [Related]
33. Neurobiology of cognitive remediation therapy for schizophrenia: a systematic review. Thorsen AL; Johansson K; Løberg EM Front Psychiatry; 2014; 5():103. PubMed ID: 25177300 [TBL] [Abstract][Full Text] [Related]
34. Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates. Vita A; Minelli A; Barlati S; Deste G; Giacopuzzi E; Valsecchi P; Turrina C; Gennarelli M Front Pharmacol; 2019; 10():402. PubMed ID: 31040787 [TBL] [Abstract][Full Text] [Related]
35. Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study. Yasui-Furukori N; Muraoka H; Hasegawa N; Ochi S; Numata S; Hori H; Hishimoto A; Onitsuka T; Ohi K; Hashimoto N; Nagasawa T; Takaesu Y; Inagaki T; Tagata H; Tsuboi T; Kubota C; Furihata R; Iga JI; Iida H; Miura K; Matsumoto J; Yamada H; Watanabe K; Inada K; Shimoda K; Hashimoto R Neuropsychopharmacol Rep; 2022 Mar; 42(1):3-9. PubMed ID: 34854260 [TBL] [Abstract][Full Text] [Related]
36. A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder. O'Reilly K; Donohoe G; O'Sullivan D; Coyle C; Corvin A; O'Flynn P; O'Donnell M; Galligan T; O'Connell P; Kennedy HG BMC Psychiatry; 2019 Jan; 19(1):27. PubMed ID: 30646884 [TBL] [Abstract][Full Text] [Related]
38. Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study. Lin AS; Chan HY; Peng YC; Chen WJ BMC Psychiatry; 2019 Jul; 19(1):220. PubMed ID: 31299940 [TBL] [Abstract][Full Text] [Related]
39. Neural changes following cognitive remediation therapy for schizophrenia. Matsuda Y; Makinodan M; Morimoto T; Kishimoto T Psychiatry Clin Neurosci; 2019 Nov; 73(11):676-684. PubMed ID: 31278805 [TBL] [Abstract][Full Text] [Related]
40. Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia. Iasevoli F; Razzino E; Altavilla B; Avagliano C; Barone A; Ciccarelli M; D'Ambrosio L; Matrone M; Milandri F; Notar Francesco D; Fornaro M; de Bartolomeis A Early Interv Psychiatry; 2022 Apr; 16(4):352-362. PubMed ID: 33998142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]